Mission Statement, Vision, & Core Values (2026) of Jinhai International Group Holdings Limited.

Jinhai International Group Holdings Limited (2225.HK) is carving a multifaceted path across medical technology, logistics and investment services, with a diversified portfolio that includes significant financial assets, investment properties and right-of-use assets; the group reported a net gain of HK$20,206,000 from financial assets at fair value through profit or loss in the first half of 2025, has pursued strategic alliances such as the partnership with Medtronic Changzhou to advance spinal endoscopy, and has taken concrete corporate steps-including changes in company secretary and audit oversight-to strengthen governance while addressing shareholding concentration as of December 2024, prompting a shift toward a more diversified ownership structure and a clear operational emphasis on growth, innovation and transparency.

Jinhai International Group Holdings Limited (2225.HK) - Intro

• Primary sectors: medical technology, logistics, investment services.
• Key asset classes: financial assets, investment properties, right-of-use assets.
• Notable strategic partner: Medtronic Changzhou (spinal endoscopy collaboration).
• Corporate governance actions: changes in company secretary and enhanced audit oversight.
• Ownership: post-December 2024 initiatives reduced shareholding concentration and diversified ownership.

Mission

• Advance patient-centred medical technology solutions through strategic R&D and partnerships.
• Create stable, long-term value for shareholders via diversified investment and asset management.
• Deliver efficient logistics and services to support healthcare and related industries.

Vision

• Be a regional leader integrating medical innovation, logistics excellence and disciplined investment.
• Foster sustainable growth by leveraging strategic collaborations (e.g., Medtronic Changzhou) and asset diversification.
• Achieve transparent governance and broadened shareholder base to enhance market credibility.

Core Values

• Patient-first innovation - prioritise clinical outcomes in medical technology initiatives.
• Integrity and transparency - continuous improvement in corporate governance and disclosure.
• Prudent capital allocation - focus on diversified assets (financial instruments, properties, right-of-use assets) to manage risk and returns.
• Partnership and collaboration - pursue industry alliances to accelerate technology adoption and commercialisation.
• Accountability - strengthen audit oversight and governance roles to protect stakeholder interests.

Jinhai International Group Holdings Limited (2225.HK) Overview

• Focus areas inferred from activities: expansion in medical device supply and healthcare solutions, strategic joint ventures, and capital allocation toward growth initiatives.
• Notable strategic partner: Medtronic Changzhou - a signal of intent to participate in higher-value segments of medical technology supply chains.
• Governance emphasis: documented moves to enhance board oversight and compliance practices suggest a priority on operational integrity.

• To evolve from a regional trader/aggregator into a specialist healthcare-solution provider through partnerships, product and service diversification, and selective investments.
• To capture value across upstream manufacturing partnerships and downstream distribution channels in Greater China and adjacent markets.

• Partnership-driven development - leveraging alliances with established medtech players.
• Governance and compliance - progressive strengthening of corporate governance as a corporate priority.
• Pragmatic growth orientation - emphasis on execution, capital deployment, and market entry over public-facing slogans.

Jinhai International Group Holdings Limited (2225.HK) - Mission Statement

Jinhai International Group Holdings Limited (2225.HK) does not publish a single, formal vision statement. The company's strategic actions, capital allocation and public disclosures, however, reveal consistent priorities that together form an implicit vision centered on healthcare-related innovation, financial growth and improved corporate governance.

• Healthcare innovation: strategic partnership with Medtronic Changzhou signals emphasis on advanced medical device/service collaboration.
• Financial growth and stability: portfolio allocations into financial assets and property holdings aim to generate recurring returns and capital appreciation.
• Diversified stakeholder base: moves to broaden shareholding structure indicate intent to engage wider investor groups and reduce concentration risk.
• Operational excellence and transparency: steps to strengthen corporate governance reflect a drive toward better disclosure, controls and accountability.
• Practical orientation: preference for strategic initiatives and investments over issuing a standalone aspirational vision statement.

Key public identifiers and high-level reported items:

• Operational indicators implied by the company's actions:
  • Capital deployed into treasury/financial instruments and property to smooth earnings volatility.
  • Partnership-driven R&D or commercialization pathways (healthcare devices/services) rather than in-house heavy manufacturing scale-up.
  • Governance initiatives aimed at aligning minority shareholder protections with Hong Kong listing standards.

For more historical context, ownership detail and mission background, see: Jinhai International Group Holdings Limited: History, Ownership, Mission, How It Works & Makes Money

Jinhai International Group Holdings Limited (2225.HK) - Vision Statement

• Strategic diversification: building complementary revenue streams across manufacturing, property and financial investments.
• Collaborative innovation: leveraging partnerships (e.g., Medtronic Changzhou) to access technology and markets.
• Financial resilience: prioritising recurring income, liquid financial assets and property portfolios to stabilise earnings.
• Governance and transparency: incremental improvements to corporate governance and shareholder engagement.
• Operational excellence over rhetoric: emphasis on execution, with fewer public value proclamations.

Operational evidence of the vision can be summarised in key metrics and initiatives:

Representative financial snapshot (illustrative of the company's focus areas):

• Inference on core values: although Jinhai does not publish a formal core-values statement, its activities imply priorities of collaboration, financial prudence, inclusivity in shareholder relations, integrity in governance, and a bias toward execution over public declarations.
• Investor implications: the company's asset mix and partnership-driven approach aim to reduce volatility and capture growth from technology-enabled manufacturing and property appreciation.